Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-07-02 Sale | 2024-07-03 5:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 9,394 | $25.28 | $237,480 | 127,107 (Direct) | View |
2024-01-05 Sale | 2024-01-08 5:17 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 74 | $33.89 | $2,508 | 136,501 (Direct) | View |
2023-07-03 Sale | 2023-07-06 6:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 8,925 | $35.31 | $315,142 | 61,575 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-04 Option Award | 2024-01-08 5:17 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 75,000 | $0 | 136,501 (Direct) | View |
2023-01-04 Option Award | 2023-01-05 7:21 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 500 | $0 | 70,500 (Direct) | View |
Ownership | 2022-06-29 7:11 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer | 0 | $0 | 70,000 (Direct) | View |